CWEB Stock Overview
Charlotte's Web Holdings, Inc. is involved in the farming, manufacture, marketing, and sale of hemp-derived cannabidiol (CBD) wellness products.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Charlotte's Web Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.24 |
| 52 Week High | CA$0.63 |
| 52 Week Low | CA$0.18 |
| Beta | 2.17 |
| 1 Month Change | -18.64% |
| 3 Month Change | 33.33% |
| 1 Year Change | -20.00% |
| 3 Year Change | -95.26% |
| 5 Year Change | -98.73% |
| Change since IPO | -97.53% |
Recent News & Updates
Little Excitement Around Charlotte's Web Holdings, Inc.'s (TSE:CWEB) Revenues As Shares Take 26% Pounding
May 11
Charlotte's Web Holdings, Inc. (TSE:CWEB) Surges 33% Yet Its Low P/S Is No Reason For Excitement
Mar 27Recent updates
Little Excitement Around Charlotte's Web Holdings, Inc.'s (TSE:CWEB) Revenues As Shares Take 26% Pounding
May 11Charlotte's Web Holdings, Inc. (TSE:CWEB) Surges 33% Yet Its Low P/S Is No Reason For Excitement
Mar 27Not Many Are Piling Into Charlotte's Web Holdings, Inc. (TSE:CWEB) Stock Yet As It Plummets 28%
Feb 09Is Charlotte's Web Holdings (TSE:CWEB) Using Too Much Debt?
Oct 08Analysts Just Made A Major Revision To Their Charlotte's Web Holdings, Inc. (TSE:CWEB) Revenue Forecasts
Aug 12Charlotte's Web Holdings (TSE:CWEB) Has Debt But No Earnings; Should You Worry?
Jul 09Some Charlotte's Web Holdings, Inc. (TSE:CWEB) Analysts Just Made A Major Cut To Next Year's Estimates
Aug 11Will Charlotte's Web Holdings (TSE:CWEB) Spend Its Cash Wisely?
May 10Newsflash: Charlotte's Web Holdings, Inc. (TSE:CWEB) Analysts Have Been Trimming Their Revenue Forecasts
Aug 14The Charlotte's Web Holdings, Inc. (TSE:CWEB) Analysts Have Been Trimming Their Sales Forecasts
May 13Charlotte's Web Holdings' (TSE:CWEB) Shareholders Are Down 35% On Their Shares
Jan 07
Shareholder Returns
| CWEB | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -4.5% | 1.2% |
| 1Y | -20.0% | 55.7% | 11.8% |
Return vs Industry: CWEB underperformed the Canadian Pharmaceuticals industry which returned 55.7% over the past year.
Return vs Market: CWEB underperformed the Canadian Market which returned 11.8% over the past year.
Price Volatility
| CWEB volatility | |
|---|---|
| CWEB Average Weekly Movement | 14.5% |
| Pharmaceuticals Industry Average Movement | 14.4% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CA Market | 17.9% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: CWEB's share price has been volatile over the past 3 months.
Volatility Over Time: CWEB's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 164 | Bill Morachnick | www.charlottesweb.com |
Charlotte's Web Holdings, Inc. is involved in the farming, manufacture, marketing, and sale of hemp-derived cannabidiol (CBD) wellness products. The company’s products categories include hemp extract oil tinctures, such as liquid products; gummies; and capsules, CBD topical creams, and lotions, as well as products for pets under the Charlotte’s Web, ReCreate, CBD Medic, CBD Clinic, and Harmony Hemp brands. Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene, cannabigerol, cannabinol, terpenes, flavonoids, and other beneficial hemp compounds.
Charlotte's Web Holdings, Inc. Fundamentals Summary
| CWEB fundamental statistics | |
|---|---|
| Market cap | CA$38.52m |
| Earnings (TTM) | -CA$41.78m |
| Revenue (TTM) | CA$79.77m |
0.5x
P/S Ratio-0.9x
P/E RatioIs CWEB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CWEB income statement (TTM) | |
|---|---|
| Revenue | US$58.27m |
| Cost of Revenue | US$25.71m |
| Gross Profit | US$32.56m |
| Other Expenses | US$63.08m |
| Earnings | -US$30.52m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.19 |
| Gross Margin | 55.88% |
| Net Profit Margin | -52.37% |
| Debt/Equity Ratio | 91.6% |
How did CWEB perform over the long term?
See historical performance and comparison